Skip to main navigation

Investor Relations

  • Company
    • Our Company
    • Senior Leadership
    • Board of Directors
    • Strategic & Scientific Advisory Board
    • Global Locations
    • Contact Us
  • Technology
    • Our Technology
    • Gene Therapy
    • RNA Medicine
    • Technology Platform
    • Therapeutic Applications
    • Strategic Partnerships
    • Manufacturing Excellence
  • Product
    • Our Product
    • SareptAssist Patient Support™
  • Pipeline
    • Our Pipeline
  • Community
    • For Community
    • Route 79, The Duchenne Scholarship Program
    • Clinical Trials
    • Disease Resources
    • Grants, Sponsorships, Fellowships & IIS
    • Compassionate Use Policy
    • Managed Access Program
  • Investors
    • For Investors
    • News
    • Events and Presentations
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Fundamentals
    • Analyst Coverage
    • Information Request
    • FAQs
  • Our Team
    • Join Our Team
    • Working at Sarepta
    • Career Opportunities

SareptAssist™ Patient Support | 1-888-727-3782

Menu
Home

Investor Relations

  • Company
    • Our Company
    • Senior Leadership
    • Board of Directors
    • Strategic & Scientific Advisory Board
    • Global Locations
    • Contact Us
  • Technology
    • Our Technology
    • Gene Therapy
    • RNA Medicine
    • Technology Platform
    • Therapeutic Applications
    • Strategic Partnerships
    • Manufacturing Excellence
  • Product
    • Our Product
    • SareptAssist Patient Support™
  • Pipeline
    • Our Pipeline
  • Community
    • For Community
    • Route 79, The Duchenne Scholarship Program
    • Clinical Trials
    • Disease Resources
    • Grants, Sponsorships, Fellowships & IIS
    • Compassionate Use Policy
    • Managed Access Program
  • Investors
    • For Investors
    • News
    • Events and Presentations
    • Corporate Governance
    • Stock Information
    • SEC Filings
    • Fundamentals
    • Analyst Coverage
    • Information Request
    • FAQs
  • Our Team
    • Join Our Team
    • Working at Sarepta
    • Career Opportunities

 

Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates.
Email Alerts
Sign up to receive Sarepta Therapeutics’ e-mail alerts.
Click here to subscribe.

Sidebar - Investor Menu

  • News
  • Events and Presentations
  • Corporate Governance
  • Stock Information
  • SEC Filings
  • Fundamentals
  • Analyst Coverage
  • Information Request
  • FAQs
  • Sarepta Therapeutics 2019 Corporate Presentation

    10/30/19
    Sarepta Therapeutics 2019 Corporate Presentation 2.9 MB
  • Latest Annual Report

    04/23/19 ( FY 2018 )
    Latest Annual Report 1.5 MB
  • R&D Day 2018 Presentation

    06/19/18
    R&D Day 2018 Presentation 12.7 MB

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Contacts

Sarepta Therapeutics First Quarter 2019 Earnings Call

05/8/19
4:30 PM EDT

Click here for webcast

Supporting Materials

1Q 2019 Forward Looking Statement 206.5 KB
  • Sarepta Therapeutics 2019 Corporate Presentation

    10/30/19
    Sarepta Therapeutics 2019 Corporate Presentation 2.9 MB
  • Latest Annual Report

    04/23/19 ( FY 2018 )
    Latest Annual Report 1.5 MB
  • R&D Day 2018 Presentation

    06/19/18
    R&D Day 2018 Presentation 12.7 MB

Shareholder Tools

  • Print Page
  • RSS Feeds
  • Contacts
Sarepta Therapeutics
215 First Street
Cambridge, MA 02142
Follow
© 2019 Sarepta Therapeutics All rights reserved.

Footer menu

  • Privacy Policy
  • Terms of Use
  • Contact